Liraglutide Treatment to Patients With Severe Renal Insufficiency

NCT01394341 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
End-stage Renal Disease

Interventions

DRUG: Liraglutide

Sponsor

Bo Feldt-Rasmussen

Collaborators

[object Object]
[object Object]